header logo image


Page 52«..1020..51525354..6070..»

Archive for the ‘Diabetes’ Category

Methodist Healthcare lifestyle coaches help reduce risk of type 2 diabetes – wreg.com

Wednesday, May 31st, 2017

MEMPHIS, Tenn. Methodist Healthcare is using lifestyle coaches to help patients reduce their risks of developing type 2 diabetes.

The disease affects the way the body processes insulin and blood sugar, and can lead to serious health problems like kidney damage, nerve damage, the need for amputation or blindness.

At Methodist, patients at high risk for developing type 2 diabetes can take part in free group meetings with a lifestyle coach.

They year-long program is designed to teach them how to eat better and lose weight.

When people are prediabetic, weight loss is one of the most important things we can modify during that stage. What we want to concentrate on is developing healthier eating habits overall rather than dieting. If you can develop healthy habits that`s something you can sustain for a longer time, said Dr. Lindsey French.

The Centers for Disease Control said you can cut in half your risk of developing the disease by losing five to seven percent of your body weight, improving food choices and increasing physical activity to at least 150 minutes per week.

For more information on the Diabetes Prevention Program call (901) 516-6616.

Quiz: Could you have prediabetes?

35.149534 -90.048980

Excerpt from:
Methodist Healthcare lifestyle coaches help reduce risk of type 2 diabetes - wreg.com

Read More...

Real estate bigs teaming up at Chelsea Piers to fight diabetes | New … – New York Post

Wednesday, May 31st, 2017

The real estate industry will be holding its second annual JDRF Real Estate Games at Chelsea Piers to raise money to fund Type One diabetes (T1D) research.

Jim Whelan, an executive vice president of the Real Estate Board of New York (REBNY), who is also on the local JDRF chapters board of directors, is once again organizing the June 15 event.

Real Estate is a competitive industry and this is a different way to exhibit that competition, said Whelan, whose teenager, Jack, was diagnosed with T1D four years ago.

Last year, 19 teams raised over $82,000 and this year $220,00 has already come in.

So far, 20 ten-person teams from the citys top real estate companies have signed on to compete in six events. These include dodgeball, hot shot basketball, a relay race, and a rock climbing relay that last year was won by the REBNY team.

New this year is the challenging sport stacking that uses a dozen cups to see who is really physically fit, and a pass, catch and end zone dance competition that will get bystanders cheering for their favorite quarterbacks and receivers.

The event even has its own hashtag, #JDRFgames.

Teams already involved include AECOM Tishman, Brookfield Properties, The Carlyle Group, Douglaston Development, The Durst Organization, Eastdil Secured, Glenwood Management, Hines, JDS Development Group, JLL, L&M Development Partners, Langan, REBNY, Savills Studley, Silverstein Properties, SL Green Realty Corp., Tishman Speyer, TF Cornerstone, and Two Trees Management Company.

Participants will later stroll to the Sunset Terrace for a networking party.

Go here to read the rest:
Real estate bigs teaming up at Chelsea Piers to fight diabetes | New ... - New York Post

Read More...

Dont’a Hightower supports mom by rallying awareness for fight vs … – Boston Herald

Wednesday, May 31st, 2017

FOXBORO -- Patriots linebacker Dont'a Hightower is continuing to do right by his mother, as he hosted another event tonight to raise awareness for diabetes.

Hightower hosted a private screening of Wonder Woman at Patriot Place for a group of women who face daily struggles with diabetes. Its a cause that has been personal for Hightower, whose mother, LTanya, was diagnosed with diabetes a couple years ago. His grandmother and aunt have also been affected.

My mom is my Wonder Woman, so what better movie to do it to? Hightower said.

Hightower has also hosted annual Monday Night Football watch parties since 2015 to raise money for the American Diabetes Association. Despite Hightowers loud presence in a Patriots uniform, he tries to stay out of the spotlight off the field, but his mother has encouraged him to put a face to the fight against diabetes

My mom is obviously the reason why Im here, Hightower said. She made a lot of sacrifices for me and my sister. Ever since shes gotten diagnosed with diabetes, Ive tried to do as much as I could to try to promote awareness and do what I can for it. The opportunity came up, and I couldnt say no to it.

Im still not a big public person. I dont mind doing what Im doing. A lot of people appreciate it. At the end of the day, thats all that matters so I dont mind stepping out of my comfort zone for a little bit.

Hightower watched his mother struggle with daily activities upon her diagnosis, so he has tried to promote early testing to get out ahead of the disease. He knows those early tests can ease the transitional phase for diabetic patients.

I know how hard it is to see and feel that change in the life that they go through, Hightower said. If I can change one or two peoples chances in that, it means a lot more to me than youll ever know.

Hightowers mother attended his Monday Night Football watch party last season in Norwood, but she stayed home Tuesday night to tend to her gardening. Hightower got a kick out of that, but there was also a sense of pride because she couldnt handle those household responsibilities a couple years ago.

I guess her lawn was more important, Hightower cracked. She is able to do stuff like that now. Earlier when she got diagnosed, she wasnt able to. She is doing well. She is healthy. Thats all I can ask for.

View original post here:
Dont'a Hightower supports mom by rallying awareness for fight vs ... - Boston Herald

Read More...

First snapshot of diabetes receptor may mean new drugs – Futurity: Research News

Tuesday, May 30th, 2017

Researchers have captured the first cryo-electron microscopy images of a key cellular receptor for diabetes in action.

The findings, published in Nature, reveal new information about workings of G protein-coupled receptorswhich are intermediaries for molecular messages related to nearly every function within the human body.

G protein-coupled receptors, often shorthanded as GPCRs, reside in the membrane of cells, where they detect signals from outside of the cell and convey them to the inside to be acted upon. They respond to signals including sensory input like light, taste, and smell, as well as to hormones and neurotransmitters.

The new, near atomic-resolution images provide an incredibly detailed look at how these important receptors bind to and transmit signals from peptide hormones.

The team revealed how the hormone GLP-1 (Glucagon-like peptide-1) binds to its receptor on the outside of a cell, and how this causes changes to the arrangement of the part extending into the cellwhich then engages and activates the G protein.

GLP-1 plays an important role in regulating insulin secretion, carbohydrate metabolism, and appetite. It binds to the B family of G protein-coupled receptors, though information about their precise interactions have heretofore been limited by a lack of images of the complex in action.

Its hard to overstate the importance of G protein-coupled receptors, says Georgios Skiniotis, a researcher at the University of Michigan Life Sciences Institute and Medical Schooland a senior author of the study. GPCRs are targeted by about half of all drugs, and getting such structures by cryo-electron microscopy will be crucial for further drug discovery efforts. The GLP-1 receptor is an important drug target for type 2 diabetes and obesity.

The size and fragility of GPCR complexes have made them notoriously difficult to capture using the longtime gold-standard of imaging: X-ray crystallography. It took Brian Kobilka, a professor of molecular and cellular physiology at Stanford University Medical School and a senior collaborator on the paper, many years to obtain the first onewhich led to a Nobel Prize for Kobilka in 2012.

The current study was done using a cryo-electron microscopy, or cryo-EM. Cryo-EM is an evolving, cutting-edge imaging technology that involves freezing proteins in a thin layer of solution and then bouncing electrons off of them to reveal their shape. Because the frozen proteins are oriented every which way, computer software can later combine the thousands of individual snapshots into a 3D picture at near-atomic resolution.

Advances in cryo-EM now make it possible to capture protein complexes with similar resolution to X-ray crystallography, without having to force the proteins into neat, orderly crystalswhich limits the variety of arrangements and interactions that are possible.

Using cryo-EM, we can also uncover more information about how GPCRs flex and move, says Yan Zhang, a postdoctoral researcher in Skiniotis lab and a co-lead author of the paper. And we can observe functional changes in complexes that are difficult, if not impossible, to crystallize.

Grants from the National Institutes of Health supported the work. Additional study authors are from the University of Michigan, ConfometRx, and Stanford University.

Source: University of Michigan

Read more:
First snapshot of diabetes receptor may mean new drugs - Futurity: Research News

Read More...

Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure – Labiotech.eu (blog)

Tuesday, May 30th, 2017

Imcyse will run its first clinical trial testing a specific immunotherapy that could finally provide a cureto autoimmune diseases.

Imcyse, a Belgian biotech spunout from the Katholieke Universiteit Leuven in 2010,just announced it has received approval from Belgian and British regulatory authorities to launch a Phase Ib trial in patients with type 1 diabetes. The study is backed with funding from the EU through the EXALT program, which has a budget of 6M over 5 years to promote the development of a cure for type 1 diabetes.

The trial, run in collaboration with the French Inserm, will be run in 18 sites across Belgium, Denmark, France, Germany, and the UK. It will be the first study in humans testing Imcysesimmunotherapy technology, which is aimed at stopping the destruction of insulin-producing beta pancreaticcells in patients diagnosed with the disease within 6 months before the trial, when not all beta cells have yet been eliminated. Resultsare expected at the end of 2018.

Imcysedevelops Imotopes,modified peptides thatinduce cytolytic CD4 T cells to kill other immune cells involved in the destruction of a specific target, in this case insulin-producing cells,without affecting any other functions of the immune system. The peptides are composed of an epitope of the targeted antigen and a specific thioredox motif.

An Imotope therapy that could be used to treat the very early stages of diabetes or prevent its onset would be a major breakthrough for patients and for public health, Christian Boitard,the trials principal investigator, from the Inserm and Cochin Hospital in Paris, said in a statement.

Indeed, the technology aims to cure severe autoimmune and inflammatory diseases for which existing therapies can only, at best, attenuate the symptoms and slow down its progress. For type 1 diabetes, which affects over 40 million people worldwide, the incidence is rapidly increasing, particularly in younger children. However, the only treatment option to date is daily glucose control and insulin injections for life.

One of the alternatives currently under development is transplantation. With that aim, the British Catapult and the Belgian Orgenesis are growing pancreatic cells in the lab. NeoVacs, in France, has a different approach that resembles more that of Imcyse; a vaccine for type 1 diabetes, currently in the preclinical stage.

Imcyse is already planning to exploit the potential of its technology, with a trial in patients with multiple sclerosis scheduled for next year. In the future, the company could also be going afterrheumatoid arthritis, graft rejection, allergic asthma and rare diseases such as myasthenia gravis or neuromyelitis optica. On top of that, the technology could also act as an add-on to prevent patients from becoming immune to biological drugs, which is a grave problemwhen it affects life-saving drugs.

Images via Becris / Shutterstock; Imcyse

Read more from the original source:
Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure - Labiotech.eu (blog)

Read More...

New Startup Aims to Change Diabetes Management – Medical Device and Diagnostics Industry

Tuesday, May 30th, 2017

Clinical studies are underway for a new advanced digital therapy app from Amalgan Rx that can optimize fasting glucose levels in patients with type 2 diabetes.

Kristopher Sturgis

Amalgam Rx, a new digital health company launched this month, might be one of the startups in 2017 worth keeping an eye onespecially if youre one of the 30 million people managing type 2 diabetes in this country. The digital health pioneers just announced the launch of their first next-gen technology known as iSage Rx, the worlds first FDA-cleared insulin titration app for all brands of basal insulin.

One of the painstaking requirements for patients who manage type 2 diabetes is the need to inject insulin on a daily basis to help control blood sugar levels in the body. Typically, doctors will prescribe sub-optimal doses of insulin as they observe how each individual patients body reacts. With the new iSage app, doctors will now be able to choose from multiple clinically-validated basal insulin algorithms so that they can individually tailor insulin level treatments to the specific needs of each patient.

Suzanne Clough, MD, the chief medical officer and cofounder of Amalgam Rx, said the company is currently recruiting patients for an in-depth clinical study that can examine all of the insulin algorithms that will help the company polish a technology that can titrate all brands of insulin. This will provide patients with a tool that can help them consistently reach their glucose targets.

The clinical trial will demonstrate proof of concept, Clough said, and is expected to enroll 30 patients in the treatment arm. This will be compared against a matched retrospective control group. The study is slated to be completed this year, with findings anticipated to be shared in 2018.

Clough said that the iSage technology was designed to be easy and intuitive so that virtually any physician can share the technology with their patients with ease. The system comes with telephone support and training programs to help familiarize the physicians with the platform, and can even be customized to fit patient-specific treatment protocols.

A physician can simply input some basic information about the patient, such as their name and prescribed insulin to register them in the system, Clough said. They can then choose the algorithm that best fits the patients needs, or we can help them customize and save algorithms if they want to use their own treatment protocols. In a way, the system can allow them to have standing orders that can be implemented by a nurse or medical assistant. It should take less than a minute for the office staff to complete the prescription, and once patients use the product, providers can access their data online and make updates when necessary.

The iSage Rx technology will be the first in what the company hopes will be a diverse line of clinically validated digital health therapies that can empower and engage patients with chronic diseases. Ryan Sysko, CEO and cofounder of Amalgam Rx said that innovative new digital health platforms can transform chronic disease management, and that Amalgam Rx can leverage these new technologies to enable patients to self-manage their condition without so many of the costs that come with many of the advanced platforms currently available.

Were incredibly passionate about the potential for digital health to transform the way that care for chronic disease management is delivered, he said. If we can develop and scale digital health solutions that are engaging and effective, we have a tremendous opportunity to significantly improve patient outcomes and reduce healthcare costs.

That's something Amalgam Rx has set out to do with their very first product. The company brought together experienced members from research and development, testing, regulatory, and commercialization backgrounds to collaborate and work together to create new digital therapies that are accessible and easy to use.

Were developing a platform that combines the necessary clinical, behavioral, and psychological interventions and technologies to support patients across many chronic disease domains, Sysko said. Our technology architecture will allow potential partners to pick and choose from the interventions to create custom solutions.

The company has already partnered with a life sciences company to help bring the iSage Rx to market, and Sysko said that Amalgam Rx has plans to announce a new partnership in the coming months that will forge a new application focused on psoriasis and psoriatic arthritis. He said that growing the companys non-diabetes partnerships will be a key to growing their success beyond 2018, and that new digital health technologies will be crucial when it comes to enabling patients to self-manage chronic diseases.

Our hope is to leverage all of our experience in developing and commercializing digital health products in combination with the latest cutting edge technologies to engage and support patients with chronic diseases, he said. We believe this is a key missing component in healthcare. If we can more effectively support and teach a patient self-management, were bound to improve healthcare outcomes and reduce costs.

Kristopher Sturgis is a freelance contributor to MD+DI.

[Images courtesy of AMALGAM RX]

See the rest here:
New Startup Aims to Change Diabetes Management - Medical Device and Diagnostics Industry

Read More...

Now, a new treatment can prevent diabetic patients from amputation – Economic Times

Tuesday, May 30th, 2017

TORONTO: Scientists have developed a new therapeutic approach that could save diabetic patients from amputation by promoting wound healing.

Diabetic patients frequently have lesions on their feet that are very difficult to heal due to poor blood circulation. In cases of serious non-healing infections, a decision to amputate could be made.

"With this treatment, we can succeed in closing wounds and promoting healing of diabetic ulcers, we might be able to avoid amputations," said Jean-Francois Cailhier, nephrologist at University of Montreal Hospital Research Centre (CRCHUM) in Canada.

We discovered a way to modify specific white blood cells - the macrophages - and make them capable of accelerating cutaneous healing, researchers said.

It has long been known that macrophages play a key role in the normal wound healing process. These white cells specialise in major cellular clean-up processes and are essential for tissue repair, researchers said.

They accelerate healing while maintaining a balance between inflammatory and anti-inflammatory reactions (pro-reparation).

"When a wound does not heal, it might be secondary to enhanced inflammation and not enough anti-inflammatory activity," Cailhier said.

"We discovered that macrophage behaviour can be controlled so as to tip the balance towards cell repair by means of a special protein called Milk Fat Globule Epidermal Growth Factor-8, or MFG-E8," Cailhier said.

Researchers showed that when there is a skin lesion, MFG-E8 calls for an anti-inflammatory and pro-reparatory reaction in the macrophages. Without this protein, the lesions heal much more slowly.

The team then developed a treatment by adoptive cell transfer in order to amplify the healing process.

Adoptive cell transfer consists in treating the patient using his or her own cells, which are harvested, treated, then re-injected in order to exert their action on an organ.

This immunotherapeutic strategy is usually used to treat various types of cancer, researchers said.

This is the first time it has been shown to also be useful in reprogramming cells to facilitate healing of the skin, they said.

"We used stem cells derived from murine bone marrow to obtain macrophages, which we treated ex vivo with the MFG-E8 protein before re-injecting them into the mice, and we quickly noticed an acceleration of healing," said Patrick Laplante, research assistant at CRCHUM.

"If we were to inject the MFG-E8 protein directly into the body there could be effects, distant from the wound, upon all the cells that are sensitive to MFG-E8, which could lead to excess repair of the skin causing aberrant scars named keloids," Cailhier said.

The major advantage [of this treatment] is that we only administer reprogrammed cells, and we find that they are capable of creating the environment needed to accelerate scar formation, researchers said.

This advanced personalised treatment could also make all the difference in treating cases of challenging wounds.

The study was published in the Journal of Investigative Dermatology.

Go here to read the rest:
Now, a new treatment can prevent diabetic patients from amputation - Economic Times

Read More...

Kidneys from deceased diabetes patients may be organ donation source – CBS News

Monday, May 29th, 2017

People who received kidneys from non-living donors with diabetes were less likely to die than those who stayed on the wait-list.

istockphoto

Kidneys from deceased diabetic donors can save the lives of patients on the transplant wait-list, researchers say.

For the study, investigators compared U.S. data from more than 8,100 recipients of kidneys from deceased donors who'd had diabetes with data from people on the kidney transplant wait-list. The patients were followed for an average of nearly nine years.

People who received kidneys from diabetic donors were 9 percent less likely to die during that follow-up period than those who were still on the wait-list or were seeking a kidney from a non-diabetic donor, the study found.

The people who benefited most from diabetic donor kidneys were those who were most likely to die while on the wait-list, the researchers said.

Play Video

A growing number of families who have lost a relative to a drug overdose have found comfort by donating their loved one's organs. Kenneth Craig t...

But poor-quality kidneys from deceased diabetic donors did not improve survival chances, the findings showed.

And people under age 40 didn't benefit from diabetic donor kidneys, according to study author Dr. Jordana Cohen. She is an instructor at the University of Pennsylvania Perelman School of Medicine.

More than 100,000 people are on the U.S. kidney transplant wait-list. The study findings suggest that kidneys from deceased diabetic donors may help relieve the shortage of organs.

"As kidney disease has become increasingly common in the United States over the past few decades, the need for kidneys to be donated far exceeds the number of available kidneys," Cohen said in an American Society of Nephrology news release.

"As a result, poorer-quality kidneys are increasingly being used as a way to try to decrease transplant waiting times and thus decrease the number of people who die while waiting for a kidney transplant," she explained.

Play Video

Milwaukee judge Derek Mosley is back on the bench after receiving a life-saving kidney transplant. The organ donor was his friend and colleague, ...

The study was published online May 25 in theClinical Journal of the American Society of Nephrology.

The author of an accompanying editorial, Dr. Richard Formica Jr., said the study findings support the use of deceased-donor kidneys that would likely be discarded.

"However, as important as this finding is," Formica said, "it is necessary to view it in the context of the larger problem facing the nephrology community as it struggles to care for patients with end-stage renal disease."

Formica, a professor and director of transplant medicine at Yale University School of Medicine, said that only a fraction of money spent to treat end-stage kidney disease goes to kidney transplantation, even though it is better than dialysis and costs less.

"It is unfortunate that despite spending 17.4 percent of its [gross domestic product] on health care, the United States does not focus more of its resources on solving the problem through increasing access to kidney transplantation," he concluded.

2017 HealthDay. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Read more here:
Kidneys from deceased diabetes patients may be organ donation source - CBS News

Read More...

First Indy 500 Driver with Diabetes Talks About Racing, Life with His Disease – Healthline

Friday, May 26th, 2017

It all started with a skin rash.

Ten years ago, race car driver Charlie Kimball went to his doctor to check out that small rash on his arm.

In the course of their conversation, the physician learned that Kimball had also been unusually thirsty in recent days.

When he weighed Kimball, the doctor discovered his patient had lost 25 pounds in five days.

He immediately suggested Kimball be tested for diabetes.

Kimball admits he was pretty clueless about the disease. He even asked his doctor if he could prescribe antibiotics for it.

I didnt know what it was or what it involved, Kimball told Healthline.

He soon found out when he was officially diagnosed at age 22 with type 1 diabetes.

Since that time, Kimball has become educated about diabetes.

He has also adjusted his life, both at home and behind the wheel of his race car.

A few years after his diagnosis, Kimball became the first person with diabetes to be allowed to drive in the Indianapolis 500.

On Sunday, he will compete in his seventh Indy 500 race.

As he circles that famed track the required 200 laps, Kimball will have a water bottle and a container of orange juice by his side.

Hell also be watching his blood glucose level on his dashboard.

Read more: Athletes with diabetes to follow on social media

Kimball concedes his diabetes diagnosis was a bit of a shock.

At age 22 you feel 10 feet tall and bulletproof, he said.

Kimball immediately had to start changing his daily routine.

He now takes insulin four times per day. One dose is a long-lasting insulin he takes in the morning. The other three are fast-acting insulin he takes after each meal.

Kimball also watches his diet much more closely.

He has learned that the carbohydrates in pizza, for example, take longer to enter the blood stream than most foods. He learned that corn has carbohydrates, too.

Kimball was initially worried about whether hed be able to continue race car driving.

I was concerned about getting back in my race car, he recalled. The race car is the only place I feel really alive.

That involved more than just driving.

Race car drivers are athletes.

They are handling vehicles without power steering that are traveling around 200 miles an hour.

The stress keeps their heart rate high throughout an entire three-hour race. They can lose seven pounds of water weight due to the heat of the car. And they can burn more than 1,100 calories in a single race.

Im always concerned about the safety element and the performance element, he said.

Kimball quickly learned, however, that his new dietary routine was actually enhancing his skills.

It helps me be a better athlete, he commented.

During his races, Kimball wears special sensors on his skin that monitor his body functions.

On his dashboard, he can monitor his blood glucose level and other health-related data along with his cars speed and how many laps he has completed.

Kimball said it isnt a coincidence hes the first Indy 500 driver with diabetes.

Until recent years, there wasnt the technology to provide enough support and assistance to a driver with this particular condition.

In addition, Kimball said, most people with type 1 diabetes are diagnosed when they are children.

At that stage, most kids with the disease dont envision becoming a race car driver.

Kimball, on the other hand, was already doing it.

I wasnt going to let diabetes get in the way of my lifes dream, he said.

Read more: NASCAR driver getting the word out on colorectal cancer

Kimball hopes his drive to continue his race car career will inspire children and others with diabetes.

He said he wants youngsters to feel like they still can do whatever they want, whether its being an athlete, a rock climber, or a chief executive officer.

I want them to be able to chase their dreams, he said.

Kimball is also participating in a program at Michigan State University to study exercise physiology and race car driving.

David Ferguson, PhD, an assistant professor of kinesiology, oversees the program. Ferguson has been doing this kind of research for 12 years.

When Kimball came along, Ferguson saw an opportunity to hone his research even more.

Charlie is a good model for us to work with, Ferguson told Healthline.

One of the more interesting experiments the researchers have worked on is how driving on an oval track seemed to be a more difficult task for Kimball than driving on a more winding, surface street race course.

To discover what was happening, the researchers outfitted Kimball with a clear plastic box that encased his body from the waist down. The case was accompanied by some wooden blocks, cushions, and a bicycle seat.

By taking readings with the box, the researchers discovered that the blood in Kimballs lower legs was pooling more on oval courses because there are stronger g-forces.

With that knowledge, they set up a training schedule that exposed Kimball to that type of g-force to help him condition himself for it.

Ferguson said they hope to use what they learn from their experiments with Kimball to help the general population with diabetes management.

For Kimball, all of this helps him when hes on the race track.

The past two years, he has finished third and fifth in the Indy 500.

Hes hoping for an even better finish on Sunday.

If you want to keep track, Kimball will be in the car with the number 83 and the Novo Nordisk sponsor decals.

Read more: World Cup soccer stars next goal is to conquer lupus

Read more here:
First Indy 500 Driver with Diabetes Talks About Racing, Life with His Disease - Healthline

Read More...

Free diabetes testing in Torrevieja and Murcia – RTN Newspaper

Friday, May 26th, 2017

THE QUIRONSALUDhospitals in Torreviejia and Murcia will be conducting free testing for diabetes next Monday May 29, between the times of 09.00h and 11.00h to coincide with World Nutrition Day, which falls on Sunday.

Obesity, physical inactivity and poor nutrition increase the number of obese and diabetic people every year. People are unaware of the fatal consequences of this chronic disease as diabetes is a condition that is triggered when the body does not produce enough insulin or does not use it effectively.

There are several types: Type 1 diabetes is the most common childhood disease. The pancreas does not produce insulin, so an excess of blood sugar is created, which makes it necessary to provide the body with injected insulin.

According to Oscar Boullosa, coordinator of the Diabetes Unit of the Hospital Quirnsalud Torrevieja, type 2 diabetes is the most common, 90% of diabetic patients suffer with this type, they are generally over 40 years old, and their body does not produce enough insulin to take advantage of glucose or are resistant to it. These individuals require a balanced diet and exercise.

This multidisciplinary unit monitors all reviews of diabetic patients annually ensuring disease control.

In Spain, about 26,000 children under the age of 15 suffer from type 1 diabetes, 13% of all diabetics. More than 5,500,000 people are estimated to suffer with type 2, of whom 43% are undiagnosed, that is, they do not know they have the disease. Figures that are increasing and indicate that in 20 years could be increased by up to 55%. One in six adults are obese and one in four children are overweight, an excellent breeding ground for the illness. Diabetes can be cured and the data is clear: more than 70% of obese patients undergoing bariatric or metabolic surgery cease to become diabetic.

The effectiveness is immediate in patients with type 2 diabetes, who usually stop using insulin and medication in the weeks following the intervention, explains Dr. Juan Lujn, head of service and head of the Unit for Obesity and General Surgery and Digestive System of Hospital Quirnsalud Murcia.

Those interested in attending the Hospital Quirnsalud Murcia can request information by phone 968 011 197 or email prevencion.mur@quironsalud.es or through the web http://www.quironsalud.es/hospital-murcia

Those who wish to do so at the Hospital Quirnsalud Torrevieja can obtain all the information by phone 966 925 770 or by email prevencion.trv@quironsalud.es or through the web http://www.quironsalud.es/torrevieja/es

To perform the test it is necessary to be nil by mouth from the night before.

Visit link:
Free diabetes testing in Torrevieja and Murcia - RTN Newspaper

Read More...

CADH to host health fair; mobilizes resources through diabetes & hypertension screening and counseling – The Maravi Post

Friday, May 26th, 2017

Community members at Chinsapo township in Lilongwe going through diabates screening for funds mobilization

LILONGWE-(MaraviPost)-The Community against Diabetes & Hypertension (CADH) in Malawi, has intensified its resource mobilization through diabetes and hypertension screening, and counseling, ahead of the health fair, slated for July 29.

The screening and counseling exercise is targeting individuals, companies, and institutions of goodwill. This enabled CADH to collect monies or material in return of the services.

The health fair, which will be held in Lilongwe, will be the first of its kind focussing on all non-communicable diseases (NCDs). The health fair comes barely two months after CADH opened its counseling centre in the capital, with the central quest to upscale awareness campaigns on diabetes and hypertension.

The fair aims to increase health awareness to the public, by providing health screenings, demonstrations, and information.

Speaking in an interview with The Maravi Post a head of the health fair, CADHs Programs Manager, Thomas Psyata, said diabetes and hypertension diseases were claiming many lives silently, hence the need for the mass awareness campaign.

Psyata said that the health fair will be a platform to demonstrate the effect of community peer supporting groups in prevention and treatment of diseases.

He added that this is the reason the organization launched the resource mobilization campaign, to meet the cost of the fair. He said the fair would also motivate participants to champion self-care practices, and make positive health behavioral change.

Since we opened the counseling centre, there have been overwhelming responses from communities as far as Mzimba for our services. But our limited resources, especially human and mobility, have been our main constraints to reach more people.

With the health fair slated for July 29, this year, we hope to increase awareness on NCDs particularly diabetes, hypertension, cancer among others. This is the reason we are visiting individuals, companies, institutions with our services, and that in return, they give us money or any material to support, to help finance the health fair preparation, said Psyata.

Psyata therefore asked people to support the initiative for their own good, as it focuses on improving the health status of the nation.

Established in 2016, CADH, is serving local communities in awareness campaigns, prevention and treatment of diabetes and hypertension. CADH is operational in six districts Lilongwe, Balaka, Salima, Dedza, Rumphi and Mzimba.

According to the World Health Organization, diabetes results in high healthcare costs, loss of labour productivity, and decreased rates of economic growth.

Globally, healthcare expenditure for diabetes totaled US$465 billion in 2011, equivalent to 11% of total health spending.

Without an investment in making effective treatments for preventing diabetes complications will arise widely, and predictably rise to US$595 billion by 2030.

Continue reading here:
CADH to host health fair; mobilizes resources through diabetes & hypertension screening and counseling - The Maravi Post

Read More...

Local youngster headed to DC to lobby for T1 diabetes research funding – The Bridgton News

Friday, May 26th, 2017

Brady Chappell

By Wayne E. Rivet

Staff Writer

NAPLES He may be just nine years old, but Brady Chappell has an important message he plans to share with lawmakers.

The Naples boy is headed to Washington, D.C., this July, where he will lobby to increase funding for Type 1 Diabetes research.

Brady was selected to serve as one of two Maine delegates to the biennial JDRF Childrens Congress.

JDRF is the leading global organization funding Type 1 Diabetes (T1D) research.

Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D, according to the JDRF website.

Just last weekend, Brady was honored to be invited by U.S. Senator Susan Collins to attend the annual JDRF Gala in Manchester, N.H., where the N.H. and Maine delegates were introduced to the attendees. Brady was able to meet both Sen. Collins and Sen. Shaheen (N.H.), who were in attendance to receive awards from JDRF for their work on behalf of the T1D community. Brady was even able to sit next to Sen. Collins at dinner.

Both senators are co-chairwomen of the Senate Diabetes caucus, which was also founded by Sen. Collins.

Brady was diagnosed with T1D at the age of six. Brady a very athletic, energetic and intelligent kid was diagnosed with T1D around Valentines Day of 2014. He had been recovering from a long bout with an illness when, thankfully, his grandmother noticed he was going to the bathroom a lot. He was also looking rather thin and was uncharacteristically lethargic. Just to be sure everything was okay, his parents Tait and Jeanette Chappell made an appointment with his doctor.

Needless to say, we were blown away when the doctor took his blood sugar and said, You need to take him to the hospital immediatelyhe has Type 1 Diabetes! What? Just like that? You dont need to do more tests? This wasnt something that was even on our radar as a possibility, the Chappells said. The doctors said that we were lucky and caught it relatively early before his blood sugar, at that point over 600, had gone even higher.

While it was a startling diagnosis, the Chappells were happy for Brady that he was being taken care of and was finally feeling better. Although a bit scared, Brady took the news in stride and was resolved to learn all he could about T1D.

The resilience of children is an amazing thing. Within two weeks, he was giving himself shots, taking his own blood sugar and counting carbs. He continues to amaze us! the couple said.

T1D can feel relentless at times, with all the finger sticks and sleepless nights, managing lows. Anything that can help alleviate that feeling is a tremendous thing. Brady now uses a Dexcom CGM and loves using the Omnipod insulin pump.Both of these devices have benefited from previous JDRF funding and help to make his daily diabetes care easier to manage.

But, the Chappells believed they could do better!

Three years ago, they were very happy to join the JDRF Walk to Cure Diabetes and help to raise money to find a cure. They were overwhelmed when Bradys Bunch raised over $20,000 in the first year. They were also very happy to sponsor a JDRF Kids Walk at Bradys school, which raised an additional $5,000.

The next Bradys Bunch fundraising effort is the JDRF One Walk 5K on Sunday, Sept. 17, starting at Thornton Academy in Saco. Check-in is at 10 a.m. with a start at 11 a.m. The goal is to raise $15,000. To make a donation to team Bradys Bunch, go to http://www.jdrf.org website, under events go to One Walk, a box allows you to enter your zip code for a walk near you, select the Saco walk and you will find teams signed up for the event, click Bradys Bunch, and make a donation.

When Brady grows up, he wants to be a professional baseball player or an engineer. He loves sports, especially baseball, football, basketball and skiing.

Although constantly tracking his blood sugar can be difficult, Brady says, Diabetes doesnt stop me from doing anything. I just always have to think about diabetesI was sad when my doctor told me that unless we found a cure, I would have diabetes for the rest of my life. That made me want to find a cure.

The JDRF 2017 Childrens Congress will take place on July 2426 in Washington, D.C. Every two years, more than 150 children living with Type 1 Diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. The children, ages 4 to 17, represent all 50 states and the District of Columbia. The delegates in JDRFs Childrens Congress enjoy a once-in-a-lifetime opportunity to help members of Congress understand what life with T1D is like and why research to fund life-changing therapies until a cure can be found is so critical. They speak up on behalf of the millions of people living with T1D and the families and friends who love them.

The JDRF Childrens Congress T1D advocacy program was inspired by a boy from Massachusetts named Tommy Solo. One day, at age nine, he asked his mother, Why cant kids go to Washington and tell their representatives about what it is like to have Type 1 Diabetes and let them know that we want scientists to find a cure?

His mom and other JDRF volunteers agreed and, in 1999, the first-ever JDRF Childrens Congress took place in Washington, D.C.

Since then, ninesuccessful Childrens Congresses have been held, one every other year, and more than 1,000 kids with T1D have served as delegates. JDRF Childrens Congress has been essential to securing continued government funding of T1D research and to raise awareness of the daily burden of Americans living with this serious autoimmune disease.

Delegates form lifelong friendships, meet T1D role models, develop leadership skills, and leave Childrens Congress empowered to use their voices for the change that will improve their lives and the lives of all people affected by T1D.

Excerpt from:
Local youngster headed to DC to lobby for T1 diabetes research funding - The Bridgton News

Read More...

Gaston 5-year-old lobbying Congress for Type 1 diabetes cure – Gaston Gazette

Thursday, May 25th, 2017

Eric Wildstein Gazette staff TheGazetteEric

Hes only 5 years old, but hes preparing to advocate for juvenile diabetes research before Congress.

Miles Bone spent Wednesday morning engaged in a wild, water war with his pre-kindergarten classmates at Gaston Day School to celebrate the end of the year. After toweling off, he readied to eat a chicken nuggets lunch from Chick-fil-A with everyone.

But first, he had to prick his finger with a needle to test his blood glucose level, a ritual he must repeat several times each day as a Type 1 diabetic. He entered his glucose number into an insulin pumpwhich he wears basically 24/7that injects him with the correct amount of insulin through a tube attached to his arm to keep his blood glucose stable after eating.

We talked about last night how he wants to show people what its like to have Type 1 diabetes because a lot of people dont know, said Sara Bone, Miless mother. A lot of people dont understand what Type 1 diabetes is and how much it affects his life and how hard he has to work to take care of himself.

Type 1 diabetes, also known as juvenile diabetes, is an autoimmune disease in which a persons pancreas stops producing insulin, a hormone people need to get energy from food. Children and adults can be diagnosed suddenly at any age. It cannot be prevented and there is no cure.

Miles, who lives in Dallas with his parents and older brother, will advocate for Type 1 diabetes research on Capitol Hill in late July. He applied and was selected to be part of a delegation of about 160 children from each U.S. state and several countries representing the Juvenile Diabetes Research Foundation 2017 Childrens Congress, a bi-annual event.

The delegates will be lobbying their representatives of Congress to remind them of the vital need to continue supporting Type 1 diabetes research that could reduce the burden of the disease and ultimately find a cure.

CC 2015 Highlights from JDRF on Vimeo.

These childrenages 4 to 17will participate in a number of activities on the Hill, including a Congressional Committee hearing to share personal testimonies that highlight the daily struggles of living with Type 1 diabetes and the need for continued funding for research projects such as the Special Diabetes Program, which provides $150 million annually for Type 1 diabetes research at the National Institutes of Health.

I want Miles to one day be able to eat some pizza and not feel bad three hours later for doing it, said Sara Bone. I think that were almost there and I want him to actually know a day where he doesnt have to worry about it.

Miles was diagnosed with Type 1 diabetes just three days after his first birthday. His parents noticed he was feeling ill and scheduled a visit with his pediatrician. Miles was hospitalized with diabetic ketoacidosis, a potentially-deadly result of extremely high blood glucose and remained there for three days before his release. It was a scary time for his parents and brother, who had no family history of Type 1 diabetes and were new to caring for the condition.

It was the scariest thing that first day we brought him home, said Sara Bone. You just think how am I ever going to do this.

They would learn to balance the high and low blood glucose fluctuations that result from diabetes and how to maintain them with a proper diet. That includes keeping a close eye on what Miles eats, delivering insulin at the proper times and boosting low blood glucose with juice boxes, glucose tablets or another form of carbohydrate.

At school, Miless teachers help him to keep track of his health, though hes already handling a lot of the heavy lifting on his own. Sara Bone says its a constant balancing act and it causes Miles to miss out on or delay certain activities so that he can care for his diabetes. But she feels its already made him a stronger person.

Its made him more compassionate, she said. Its made his brother a compassionate kid. He really cares about Miles and wants to see him OK and cares about his future.

And Miles will work toward that brighter future by joining a long list of other advocates with Type 1 diabetes, such as celebrities including the NHL Hall of Fame hockey player Bobby Clarke, musicians Bret Michaels and Nick Jonas, and the late actress Mary Tyler Moore.

NASCAR Xfinity series driver Ryan Reed, 23, was diagnosed with Type 1 diabetes in 2011. He later began his nonprofit organization, Ryan's Mission, which advocates and raises money for Type 1 diabetes research.

Reed will host the Lilly Diabetes #DriveYourHealth Track Walk from 2 to 4 p.m. Friday at the Charlotte Motor Speedway. Lilly Diabetes will make a donation to the American Diabetes Association Charlotte Chapter for each participant who reaches the finish line.

Reed will also sport the Lilly Diabetes logo on his No. 16 Ford Mustang at the NASCAR Xfinity series events at the speedway this weekend.

Miles and his family have already been doing their part. The family has participated in five Juvenile Diabetes Research Foundation One Walks and mentored several families who are new to Type 1 diabetes.

As for what Miles hopes his talks with Congress will yield for type 1 diabetes, he says optimistically a cure.

You can reach Eric Wildstein at 704-869-1828 or Twitter.com/TheGazetteEric.

Read more here:
Gaston 5-year-old lobbying Congress for Type 1 diabetes cure - Gaston Gazette

Read More...

Nutrition Corner: Control diabetes with low-carbohydrate vegetable – The Sunday Dispatch

Thursday, May 25th, 2017

The Sunday Dispatch
Nutrition Corner: Control diabetes with low-carbohydrate vegetable
The Sunday Dispatch
The number of people affected by diabetes and pre-diabetes continues to grow. In our area, 11 percent of the population more than one out of 10 people have diabetes. How many are undiagnosed? Nationwide, 9.3 million, or 21 percent of the ...

Read more from the original source:
Nutrition Corner: Control diabetes with low-carbohydrate vegetable - The Sunday Dispatch

Read More...

HRRMC receives grant for diabetes prevention outreach – Chaffee County Times

Thursday, May 25th, 2017

Heart of the Rockies Regional Medical Center Foundation was one of seven local nonprofit organizations awarded a grant by the Climax Area Community Investment Fund on May 3. The fund supports programs and projects that promote health and wellness.

The $41,500 grant will support a unique partnership between Heart of the Rockies Regional Medical Center in Chaffee County and St. Vincent Hospital in Lake County to implement the National Diabetes Prevention Program, a nationally recognized diabetes prevention program. Education and improved access to quality health care can help individuals at risk for diabetes. The funds will also be used to increase the availability of fitness, nutrition and other health education in the region.

The National Diabetes Prevention Program is the most effective intervention for lifestyle change that I've seen in my 20-year career, said HRRMC Wellness Supervisor Jon Fritz.The group class is led by a trained coach and encourages increased activity and decreased caloric intake. The answers are simple but the process is challenging and that's why trained coaches follow an evidence-based curriculum which has proven effective.

Chaffee County has had an NDPP program since 2013. Lake County and St. Vincent Hospital have identified diabetes prevention as a focus in their community. HRRMC will offer assistance in starting an NDPP program while expanding classes throughout Chaffee County.

HRRMC Foundation director Kimla Robinson accepted the award along with Fritz on behalf of the hospital. We are so honored to receive the Freeport-McMoRan Climax Area Community Investment Fund Grant and partner with St. Vincent Hospital to implement a diabetes prevention program, she said.

The Climax Area Community Investment Fund was established in 2011 to focus on programs and projects that help create sustainability and reduce dependency on any single industry. Eligible programs and projects include those in the areas of education, community and economic development, environmental stewardship, and health and wellness. A committee comprised of community leaders representing diverse organizations and two Freeport-McMoRan representatives governs the Fund.

For more information on the NDPP program, call the HRRMC Wellness Department at 530-2057.

See the article here:
HRRMC receives grant for diabetes prevention outreach - Chaffee County Times

Read More...

Summer pregnancy may raise gestational diabetes risk – CNN

Thursday, May 25th, 2017

Gestational diabetes can also raise babies' risks of excessive birth weight, preterm birth, and type 2 diabetes later in life.

For this reason, it's been suggested that cold temperatures might protect against these conditions.

To study this potential connection in pregnant women, researchers looked at medical records of nearly 400,000 women living in the same urban area in Canada, in a region with wide temperature fluctuations throughout the year. Over a 12-year period, those women gave birth to more than 555,000 children.

When the researchers looked at average temperatures in the 30 days before these women gave birth, they found that the prevalence of gestational diabetes was 4.6% among those exposed to very cold temperatures (14 degrees Fahrenheit or lower), compared to 7.7% among those exposed to very hot temperatures (75 degrees Fahrenheit or higher).

That translates to a 6% to 9% relative increase in the risk of gestational diabetes for every increase of about 18 degrees Fahrenheit (or every 10 degrees Celsius), the researchers calculated.

The relationship held true even when the researchers compared two consecutive pregnancies in the same woman, which allowed them to cancel out factors such as income, ethnicity, and lifestyle habits that could also affect risk.

This may seem counterintuitive, says lead author Gillian Booth, MD, a researcher at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences in Toronto, since people might think that pregnant women would spend more time outdoors and be more active during warmer months. But the findings fit a pattern of recent research on the potential protective effects of colder temperatures, she says.

And although the researchers only looked at a single geographic region in Canada, they say the results could likely apply to other parts of North American and the world.

"Based on the study's findings we would expect pregnancies in warmer climates to be at higher risk of gestational diabetes, although we weren't able to look at that directly," Dr. Booth told Health. "I think that's a great topic for future research."

The study also suggests that gestational diabetes -- and adult-onset diabetes, which shares the same risk factors -- could become increasingly prevalent worldwide as global temperatures continue to increase.

Because the study was not a randomized trial, it was unable to show a cause-and-effect relationship. The study also did not include information about body mass index, weight gain, physical activity, or diet of the women involved. But it does "offer fairly compelling evidence that air temperature may be a modifiable risk factor for gestational diabetes," says Dr. Booth.

Strategies like using air conditioning and avoiding excess layers in the summer might influence a pregnant woman's risk of gestational diabetes, says Dr. Booth.

These may be especially important for women who have strong non-modifiable risk factors for gestational diabetes, she adds, including non-European ethnicity, family history of type 2 diabetes, or a prior pregnancy with gestational diabetes.

Join the conversation

See the latest news and share your comments with CNN Health on Facebook and Twitter.

Temperature appears to have a smaller effect on gestational diabetes than these other risk factors, but "it is one factor that might be sufficient to push someone's risk over the edge," says Dr. Booth.

And while the number of women impacted globally by temperature fluctuations may be substantial, she says, the increased risk for individual women is likely small.

Staying cool during hot weather is probably a smart idea, says Dr. Booth, but women can also protect themselves from gestational diabetes by following strategies that have been proven to lower their risk -- like achieving a healthier body weight before they conceive, and avoiding excess weight gain during pregnancy by consuming a healthy diet and being physically active.

The rest is here:
Summer pregnancy may raise gestational diabetes risk - CNN

Read More...

Cutting (research) to the bone: UMD prof to study diabetes-related skeletal fragility – SouthCoastToday.com

Thursday, May 25th, 2017

Aimee Chiavaroli achiavaroli@s-t.com

UMASS DARTMOUTH In her lab in the textiles building, Lamya Karim, assistant professor of bioengineering, showed a reporter a testing system used to break human bone samples.

The goal is to ... test how strong bone is, Karim said.

Karim received the largest National Institute of Health grant to UMass Dartmouth $616,170 to study how Type 2 diabetes weakens bones and increases risk of fractures. Also, this is the first NIH Mentored Research Scientist Career Development Award to a principal investigator at the university, officials said.

According to a news release from UMass Dartmouth, people with Type 2 diabetes are about three times as likely to break a bone than those without it, including fractures with high mortality rates such as hip fractures.

People who have diabetes actually break their bones very often, Karim said, which can be problematic, especially for older people.

Your body isnt as capable of constantly repairing the skeletal system, when it gets older versus when it was younger, she explained.

She noted people often dont know they have weak bones until they break a bone and about a quarter of people who get hip fractures die within a year due to complications.

Type 2 diabetes adds up to $245 billion in annual health care costs in the United States. Diabetes rates in the U.S. are predicted to increase up to five times by the year 2050.

About 18 percent of adults over 65 have Type 2 diabetes in Massachusetts, and about 50 percent are pre-diabetic. Bristol County has one of the highest rates of diabetes in the state, according to the news release.

The bone samples Karim is using will come from cadaver banks or from patients who are getting surgery.

In graduate school at Rensselaer Polytechnic Institute in Troy, New York, Karim worked mainly in bone mechanics and had an interest in molecular properties in bone.

Trying to get the grant was a process in the making, the professor said. Karim wrote the submission for the grant with the help of Mary Bouxsein, a mentor when Karim was a post-doctorate fellow at Beth Israel Deaconess in Boston.

She will continue to be a mentor on this project, she said.

Karim, 32, started brainstorming for the project around 2013 and went through two rounds or submissions on the grant, getting feedback on how to improve. She resubmitted it about a year ago, before she began teaching at UMass Dartmouth in September.

Student to senior investigator, everyone has a role in the project, Karim said. The bulk of it will be here at UMass.

Karims goal is to find out the underlying causes of diabetic skeletal fragility.

Itll answer a small part, Karim said about the project. There could be more questions, but Karim said she thinks thats a natural part of research.

I think for a researcher its exciting to have more unanswered questions, she said I enjoy trying to explore the unknown and figure out why things are happening the way they are.

Follow Aimee Chiavaroli on Twitter@AimeeC_SCT.

More:
Cutting (research) to the bone: UMD prof to study diabetes-related skeletal fragility - SouthCoastToday.com

Read More...

Diabetes fundraising to the tune of $60,000 earns racing … – Press-Enterprise

Thursday, May 25th, 2017

Racing enthusiast Walker Evans knows the toll diabetes can take.

I have relatives with it (diabetes), said Evans. I watched it when I was growing up.

So, the business entrepreneur has helped raise more than more than $60,000 to help fight the disease.

For these efforts, Evans was one of four men to be honored with a Father of the Year award at a banquet in Riverside on Wednesday.

Evans moved to Riverside in 1946. He initially worked in the construction business before discovering a passion for racing, from motorcycles to boats to off-road vehicles.

He is a member of the Off-Road Motorsports Hall of Fame, the Riverside California Sports Hall of Fame and the Motorsports Hall of Fame of America. He launched Walker Evans Racing in 1977. The company employs 125 people. He retired from full-time racing in 2000.

The Father of the Year award, which recognizes men for community involvement, is a partnership between the Fathers Day Council and the American Diabetes Association. The event is held in 30 cities across the nation, with the first Inland Empire Father of the Year award being presented in 2010.

Dayna Murphy, manager of development at the American Diabetes Association, said her organization is appreciative of Evans work raising money for diabetes causes.

Having the opportunity to get to know the Evans family has been so much fun. Walker and Phyllis have built an empire together and it really shows by the incredible support the community has given them through Walker being honored, said Murphy. Walker is a legend and has passed on his drive and passion to all of his children. The American Diabetes Association and Fathers Day Council really appreciate the Evans commitment to our mission and to all people affected by diabetes.

Evans realizes the importance of raising money for diabetes research, but he admits it feels good to be recognized for his work.

Its nice to be noticed for our efforts to fight this disease, said Evans.

More:
Diabetes fundraising to the tune of $60,000 earns racing ... - Press-Enterprise

Read More...

ViaCyte bags $10M for diabetes cell therapies – FierceBiotech

Thursday, May 25th, 2017

ViaCyte picked up $10 milliontofund the clinical development of its stem cell-derived treatment for patients who have Type 1 diabetes and are at risk of complications.

Specifically, the funds will be used to develop the companys PEC-Direct candidate, which treats diabetes by administering stem cell-derived pancreatic progenitor cells in an implantable device, according to a statement. These cells are designed to mature into human pancreatic cells, including insulin-secreting beta cells.

This treatment is intended for high-risk Type 1 diabetes patientsthose who experience severe hypoglycemic episodes, who have brittle diabetes, where blood glucose levels swing up and down, or who are less able or unable to spot symptoms of low blood sugar. ViaCyte plans to deliver the therapy alongside immune-suppressive drugs to prevent rejection.

Highrisk type 1 diabetes has been successfully treated with cadaver islet transplants, but adoption of islet transplants has been limited, due in part to the insufficient supply of donor material, said ViaCyte CEO Paul Laikind, in a statement. Because ViaCytes PEC01 cells are manufactured from pluripotent cells with unlimited proliferative potential, they can be made in vast numbers and therefore may be capable of solving the cell supply issue.

The new fundingwill also support the development of ViaCytes other candidate, the PEC-Encap, for patients who require insulin to control their diabetes. It comprises the Encaptra Cell Delivery System and the companys pancreatic progenitor cells. In addition to delivering the cells, the Encaptra device also protects the cells from the host immune response, cutting the need for immunosuppression.

The funding comes from some undisclosed investors as well as from W.L. Gore, JDRF and Asset Management Partners. San Diego-based ViaCyte partnered with Gore in in March to improve the Encaptra device.

We believe that ViaCytes capabilities in cell therapy for diabetes are the most advanced in the industry, and we are pleased to bring our material and device expertise to the challenge of developing a functional cure for insulinrequiring diabetes, said Edward Gunzel, technical leader for Gore PharmBIO Products, in the statement.

JDRF recently established a $42 million fund for Type 1 diabetes research, which will be managed separately from JDRF. The diabetes nonprofit has supported a number of other projects, including Sernovas Cell Pouch System, an implant that secretes cells that help control blood sugar, and the University of Torontos skin patch, which detects low blood sugar and automatically delivers the hormone glucagon to convert glycogen back into glucose.

Read more here:
ViaCyte bags $10M for diabetes cell therapies - FierceBiotech

Read More...

Roche: Diabetes patients could save thousands with new blood … – USA TODAY

Wednesday, May 24th, 2017

Type 2 diabetes can wreak havoc on your health. While lifestyle changes can help keep diabetes under control, many patients require oral medications or insulin injections as forms of treatment, too. Watch the video for how diabetes affects your body. Time

Pharmaceuticals maker Roche introduced a new blood glucose monitoring system called Accu-Chek Guide, paired with a savings card that allows patients to get the device for free as well as discounted test strips.(Photo: Roche)

Pharmaceuticals maker Roche overhauled its blood glucose monitoring system and introduced a new discounting offer that it says could save uninsured diabetics by thousands of dollars per year.

The move could help alleviate political pressure as the drug industry faces mounting scrutiny over prices. It also comes amid increasing competition among blood glucose monitoring makers as diabetes rates rise.

The new system pairs a free blood glucose meter with a smartphone app and discounted test strips. With some diabetics paying as much as $2 a strip for other offerings, the new Roche system paired with a free savings card could cut costs to as little as 40 cents per strip in the first 50-count box, then 20 cents per strip in subsequent boxes.

The nation's 29-million diabetics pay widely varying prices for testing products, in part because many of them are covered by insurance. Roches' move is likely to provide the biggest help to the uninsured.The average American diabetic paid $1,922 in out-of-pocket expenses for care in 2013, compared to $738 for someone without the condition,according to the Health Care Cost Institute.

For "the average patient, managing diabetes and acquiring all of the testing and therapy supplies can be very difficult to navigate, really complex and very often very expensive," said Brad Moore, head of Rochediabetes care in North America.

The new system offers a spill-resistant vial, a larger blood application area on upgraded strips and a light on the strip port for improved visibility when testing. The device wirelessly transmits data through Bluetooth technology to a free smartphone app that logs data.

Moore said Roche technicians worked on the new Accu-Chek Guide Systemfor at least three years, including a "very significant investment in capital."

Test strips read by devices to monitor blood glucose data are typically a significant source of profit for the pharmaceutical industry, which is under fire for its contribution to increasing health care costs. President Trump has threatened to battle drug companies over costs, while many Washington lawmakers have decried health care's effect on the average American's budget.

Although industryprices can be more than $2per strip, manufacturing costs don't typically top 15 cents, DiabeticInvestor.com analyst David Kliff told Diabetes Forecast magazine in 2012.

Roche had 8.5% market share in the blood glucose monitoring industry, trailing only Johnson & Johnson at 22.5%, according to an October 2016 report by market-research firm IBISWorld analystJonathan DeCarlo.

But competition is increasing, as big-box retail chains Target and Walmart and other retailers have introduced low-cost, private-label options. Consequently, the blood glucose monitoring industry's profit as a percentage of revenue was projected to fall from 10.1% in 2015 to 9.5% in 2016, IBISWorld'sDeCarlo estimated.

Moore declined to discuss the profitability of Roche's new test strips, which contain a new chemical makeup.

"We knew that access was a problem. We heard that from our patients," Moore said. "So the timing was perfect in that weve developed a new technology platform that the Accu-Chek Guide System is based on."

Meanwhile, drug companies are under pressure to shield patients from increasing costs, though they often blame insurers and other health care intermediaries for saddling patients with additional expenses.

With a free savings card available online, through pharmacies and at health care centers, the new Roche monitoring meter is free, the first box of 50 test strips is $19.99 and all additional boxesare $10.That's cheaper than major competitors atAmazon, Rite Aid, Walgreens, CVS and Walmart with the exception of the ReliOn Prime option at Walmart, according to data collected by USA TODAY.

Most options are more than $40 for a box, with some significantly more expensive. Accu-Chek's previous box of Aviva Plus strips ranged from $44.99 at Amazon to $109.99 at Walgreens.

The average patient tests once a day but some must test eight to 10 times a day. At those rates, savings from typical diabetes tests could range from hundreds to several thousands of dollars per year.

A recent study commissioned by Roche of 500 U.S. adults living with diabetes found that 58% "cut corners" to save money in their daily testing regiment, including by skipping tests.

Contributing: Diana Kruzman

Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.

Read or Share this story: https://usat.ly/2rS9AYg

Visit link:
Roche: Diabetes patients could save thousands with new blood ... - USA TODAY

Read More...

Page 52«..1020..51525354..6070..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick